The Radiotherapeutic Factors Associated with Reduced Risk of Progression in Patients with Oligometastatic Non-Small Cell Lung Cancer Treated with Local Ablative Radiotherapy

被引：0
|
作者：
Yang, G. [1 ]
Kim, K. H. [1 ]
Lee, C. G., Jr. [1 ]
Yoon, H. I. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2910
引用
收藏
页码：E408 / E408
页数：1
相关论文
共 50 条
  • [41] Utility of stereotactic ablative radiotherapy/stereotactic body radiation therapy in the setting of oligometastatic non-small cell lung cancer
    Song, Andrew
    Lu, Bo
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 657 - 660
  • [42] The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer
    Guerrero, Eduardo
    Ahmed, Merina
    LUNG CANCER, 2016, 92 : 22 - 28
  • [43] Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer
    Ouyang, Wen
    Yu, Jing
    Nuerjiang, Shuake
    Li, Zhijun
    Wang, Dajiang
    Wang, Xiaoyong
    Zhang, Junhong
    Xie, Conghua
    CANCER MEDICINE, 2019, 8 (10): : 4605 - 4614
  • [44] Radiotherapy for oligometastatic tumor improved the prognosis of patients with non-small cell lung cancer (NSCLC)
    Gong, Hong-yun
    Wang, Yi
    Han, Guang
    Song, Qi-bin
    THORACIC CANCER, 2019, 10 (05) : 1136 - 1140
  • [45] Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer: Past, Present, and Future
    McCall, Neal S.
    Higgins, Kristin A.
    ONCOLOGY-NEW YORK, 2021, 35 (06): : 311 - 319
  • [46] Risk factors for brain metastases in locally advanced non-small cell lung cancer patients treated with radical radiotherapy
    Xu, Xiaohong
    Chen, Gang
    Fan, Shaonan
    Zhang, Qi
    Huang, Wenhan
    Chen, Jingyao
    Ji, Weixing
    Ma, Jintao
    He, Jian
    JOURNAL OF THORACIC DISEASE, 2024, 16 (01) : 479 - 490
  • [47] The Role of Stereotactic Body Radiotherapy in Oligometastatic Non-Small Cell Lung Cancer
    Wan, Benson
    Lecavalier-Barsoum, Magali
    CURRENT ONCOLOGY, 2024, 31 (12) : 7971 - 7978
  • [48] Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
    Wujanto, Caryn
    Vellayappan, Balamurugan
    Siva, Shankar
    Louie, Alexander V.
    Guckenberger, Matthias
    Slotman, Ben J.
    Onishi, Hiroshi
    Nagata, Yasushi
    Liu, Mitchell
    Lo, Simon S.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [49] Pre-radiotherapy ctDNA risk-stratifies non-small cell lung cancer patients with oligometastatic disease
    Semenkovich, Nicholas P.
    Wang, Yun E.
    Chaudhuri, Aadel A.
    CANCER RESEARCH, 2023, 83 (07)
  • [50] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
    Leschenko, Y.
    Chebotareva, T.
    Spizhenko, N.
    Fedusenko, A.
    Sharaevskiy, O.
    Buryk, V.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39
12345